Neurodegeneration: MicroRNAs

microRNAs (miRNAs) are key regulatory RNAs that modulate gene expression in various biological processes and neurodegenerative disorders. Here are the latest discoveries pertaining to miRNAs and neurodegeneration.

April 16, 2021
Open Access

Evolutionary Changes in the Interaction of miRNA With mRNA of Candidate Genes for Parkinson's Disease.

Frontiers in Genetics
Saltanat KamenovaAnatoliy Ivashchenko
April 16, 2021

Identification of hub molecules of FUS-ALS by Bayesian gene regulatory network analysis of iPSC model: iBRN.

Neurobiology of Disease
Masahiro NogamiHideyuki Okano
April 12, 2021
Preprint
Open Access

Isolation of sensory hair cell specific exosomes in human perilymph

BioRxiv : the Preprint Server for Biology
Z. PeiHinrich Staecker
April 12, 2021
Preprint
Open Access

Drug Repurposing for Alzheimer’s Disease based on Protein-Protein Interaction Network

ResearchSquare
Negar Sadat Soleimani ZakeriHabib MotieGhader
April 12, 2021
Review

Roles of FAM134B in diseases from the perspectives of organelle membrane morphogenesis and cellular homeostasis.

Journal of Cellular Physiology
Luoyi ZhuYizhen Wang
April 8, 2021
Open Access

LONG-TERM CHRONIC CALORIC RESTRICTION ALTERS miRNA PROFILES IN THE BRAIN OF AGEING MICE.

The British Journal of Nutrition
Umit OzorhanSoner Dogan
April 10, 2021
Open Access

The emerging role of non-coding RNAs from extracellular vesicles in Alzheimer's disease.

Journal of Integrative Neuroscience
Yu-Zhong XuYu Hu
April 8, 2021

Widespread and sustained target engagement in Huntington's disease minipigs upon intrastriatal microRNA-based gene therapy.

Science Translational Medicine
Astrid VallèsPavlina Konstantinova
April 8, 2021
Open Access

MicroRNA-29 is an essential regulator of brain maturation through regulation of CH methylation.

Cell Reports
Vijay SwahariMohanish Deshmukh
April 5, 2021
Review
Open Access

Altered microRNA expression in animal models of Huntington's disease and potential therapeutic strategies.

Neural Regeneration Research
Bridget Martinez, Philip V Peplow
April 5, 2021
Open Access

Aberrant expression of microRNA-132-3p and microRNA-146a-5p in Parkinson's disease patients.

Open Life Sciences
Yu ShuChunyan Wang
April 4, 2021
Review
Open Access

News about the Role of Fluid and Imaging Biomarkers in Neurodegenerative Diseases.

Biomedicines
Jacopo Meldolesi
April 3, 2021
Open Access

Different miRNA Profiles in Plasma Derived Small and Large Extracellular Vesicles from Patients with Neurodegenerative Diseases.

International Journal of Molecular Sciences
Daisy SprovieroCristina Cereda
April 3, 2021
Review
Open Access

MicroRNAs, Parkinson's Disease, and Diabetes Mellitus.

International Journal of Molecular Sciences
Hsiuying Wang

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/neurodegeneration-microrna/f60c606d-137a-42d7-b5fe-8ce5ed81795f